Human Papillomavirus 45 Genetic Variation and Cervical Cancer Risk Worldwide

被引：28

作者：

Chen, Alyce A. ^{[1
]}

Heideman, Danielle A. M. ^{[2
]}

Boon, Debby ^{[2
]}

Gheit, Tarik ^{[1
]}

Snijders, Peter J. F. ^{[2
]}

Tommasino, Massimo ^{[1
]}

Franceschi, Silvia ^{[1
]}

Clifford, Gary M. ^{[1
]}

机构：

[1] Int Agcy Res Canc, F-69372 Lyon, France

[2] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands

来源：

JOURNAL OF VIROLOGY | 2014年 / 88卷 / 08期

关键词：

REPUBLIC-OF-CHINA; VARIANT LINEAGES; HPV INFECTION; WOMEN; POPULATION; TYPE-16; E6; PREVALENCE; NEOPLASIA; CLASSIFICATION;

D O I：

10.1128/JVI.03534-13

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Human papillomavirus 45 (HPV45) is a member of the HPV18-related alpha-7 species and accounts for approximately 5% of all cervical cancer cases worldwide. This study evaluated the genetic diversity of HPV45 and the association of HPV45 variants with the risk of cervical cancer by sequencing the entire E6 and E7 open reading frames of 300 HPV45-positive cervical samples from 36 countries. A total of 43 HPV45 sequence variants were identified that formed 5 phylogenetic sublineages, A1, A2, A3, B1, and B2, the distribution of which varied by geographical region. Among 192 cases of cervical cancer and 101 controls, the B2 sublineage was significantly overrepresented in cervical cancer, both overall and in Africa and Europe separately. We show that the sequence analysis of E6 and E7 allows the classification of HPV45 variants and that the risk of cervical cancer may differ by HPV45 variant sublineage.

引用

页码：4514 / 4521

页数：8

共 50 条

[41] Human papillomavirus in cervical cancer
Bosch F.X.
Sanjosé S.
Current Oncology Reports, 2002, 4 (2) : 175 - 184
[42] Overview of genetic and epigenetic regulation of human papillomavirus and apoptosis in cervical cancer
Yadav, Chetna
Yadav, Ritu
Chabbra, Ravindresh
Nanda, Smiti
Ranga, Shalu
Kadian, Lokesh
Ahuja, Parul
APOPTOSIS, 2023, 28 (5-6) : 683 - 701
[43] Overview of genetic and epigenetic regulation of human papillomavirus and apoptosis in cervical cancer
Chetna Yadav
Ritu Yadav
Ravindresh Chabbra
Smiti Nanda
Shalu Ranga
Lokesh Kadian
Parul Ahuja
Apoptosis, 2023, 28 : 683 - 701
[44] CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide
Senkomago, Virginia
Duran, Denise
Loharikar, Anagha
Hyde, Terri B.
Markowitz, Lauri E.
Unger, Elizabeth R.
Saraiya, Mona
EMERGING INFECTIOUS DISEASES, 2017, 23 : S101 - S107
[45] Intratype variation in 12 human papillomavirus types: A worldwide perspective
Stewart, ACM
Eriksson, AM
Manos, MM
Munoz, N
Bosch, FX
Peto, J
Wheeler, CM
JOURNAL OF VIROLOGY, 1996, 70 (05) : 3127 - 3136
[46] Human papillomavirus infection and cervical cancer risk in women with lupus erythematosus
Berthier, S
Mougin, C
Vercherin, P
Desmurs, H
Gil, H
de Wazières, B
Dupond, JL
REVUE DE MEDECINE INTERNE, 1999, 20 (02): : 128 - 132
[47] Association of human papillomavirus type 58 variant with the risk of cervical cancer
Chan, PKS
Lam, CW
Cheung, TH
Li, WWH
Lo, WK
Chan, MYM
Cheung, JLK
Cheng, AF
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (16) : 1249 - 1253
[48] Differences in the risk of cervical cancer and human papillomavirus infection by education level
Franceschi, S.
Plummer, M.
Clifford, G.
de Sanjose, S.
Bosch, X.
Herrero, R.
Munoz, N.
Vaccarella, S.
BRITISH JOURNAL OF CANCER, 2009, 101 (05) : 865 - 870
[49] Differences in the risk of cervical cancer and human papillomavirus infection by education level
S Franceschi
M Plummer
G Clifford
S de Sanjose
X Bosch
R Herrero
N Muñoz
S Vaccarella
British Journal of Cancer, 2009, 101 : 865 - 870
[50] High-risk Human Papillomavirus Testing for Cervical Cancer Screening
Totten, Stephanie P. S.
Romero, Joan Miguel
JAMA ONCOLOGY, 2021, 7 (07) : 1066 - 1067

← 1 2 3 4 5 →